Expansion of Partnership with Daewoong Pharmaceutical to Include COVID-19 Neutrali s ing Affimer Therapy
Expansion of Partnership with Daewoong Pharmaceutical to Include COVID-19 Neutrali s ing Affimer Therapy
Highly specific prototype test detects the virus spike protein at clinically relevant concentrations
With the initial focus to help guide Open Orphan in the provision of solutions to Coronavirus outbreak